CRON Cronos Group Inc

Price (delayed)

$8.22

Market cap

$2.96B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.21

Enterprise value

$1.89B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Highlights

Cronos Group's revenue has surged by 97% YoY and by 26% QoQ
The company's gross margin rose by 34% QoQ and by 25% YoY
Cronos Group's gross profit has decreased by 47% YoY but it has increased by 17% from the previous quarter
The company's quick ratio rose by 39% YoY but it fell by 31% QoQ
The net income has dropped by 173% since the previous quarter and by 106% year-on-year
Cronos Group's EPS has shrunk by 106% YoY

Key stats

What are the main financial stats of CRON
Market
Shares outstanding
360.26M
Market cap
$2.96B
Enterprise value
$1.89B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.71
Price to sales (P/S)
61.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
40.52
Earnings
Revenue
$46.72M
EBIT
-$90.21M
EBITDA
-$83.16M
Free cash flow
-$173.87M
Per share
EPS
-$0.21
Free cash flow per share
-$0.49
Book value per share
$4.8
Revenue per share
$0.13
TBVPS
$4.77
Balance sheet
Total assets
$1.93B
Total liabilities
$217.51M
Debt
$9.81M
Equity
$1.71B
Working capital
$1.17B
Liquidity
Debt to equity
0.01
Current ratio
6.63
Quick ratio
6.36
Net debt/EBITDA
12.85
Margins
EBITDA margin
-178%
Gross margin
-55.3%
Net margin
-156.5%
Operating margin
-383.9%
Efficiency
Return on assets
-3.8%
Return on equity
-4.3%
Return on invested capital
-24.2%
Return on capital employed
-5.2%
Return on sales
-193.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CRON stock price

How has the Cronos Group stock price performed over time
Intraday
2.37%
1 week
-1.67%
1 month
-13.84%
1 year
37.23%
YTD
18.44%
QTD
-13.11%

Financial performance

How have Cronos Group's revenue and profit performed over time
Revenue
$46.72M
Gross profit
-$25.83M
Operating income
-$179.35M
Net income
-$73.14M
Gross margin
-55.3%
Net margin
-156.5%
The net income has dropped by 173% since the previous quarter and by 106% year-on-year
The company's net margin has shrunk by 158% QoQ and by 103% YoY
Cronos Group's revenue has surged by 97% YoY and by 26% QoQ
The company's operating income fell by 48% YoY but it rose by 2.8% QoQ

Growth

What is Cronos Group's growth rate over time

Valuation

What is Cronos Group stock price valuation
P/E
N/A
P/B
1.71
P/S
61.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
40.52
Cronos Group's EPS has shrunk by 106% YoY
The price to book (P/B) is 39% higher than the last 4 quarters average of 1.2
Cronos Group's equity has decreased by 3.1% from the previous quarter and by 2.2% YoY
Cronos Group's revenue has surged by 97% YoY and by 26% QoQ
The price to sales (P/S) is 3.1% higher than the last 4 quarters average of 58.6

Efficiency

How efficient is Cronos Group business performance
The company's return on invested capital has shrunk by 196% QoQ
Cronos Group's return on sales has shrunk by 183% QoQ and by 104% YoY
The company's return on assets has shrunk by 175% QoQ and by 107% YoY
CRON's ROE has shrunk by 174% QoQ and by 105% YoY

Dividends

What is CRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CRON.

Financial health

How did Cronos Group financials performed over time
The total liabilities has increased by 41% QoQ but it has decreased by 36% YoY
Cronos Group's current ratio has increased by 40% YoY but it has decreased by 32% from the previous quarter
The company's debt is 99% lower than its equity
The company's debt rose by 38% YoY
Cronos Group's equity has decreased by 3.1% from the previous quarter and by 2.2% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.